
News
Press releases
April 26, 2022
Ambagon Therapeutics Appoints Gideon Bollag, Ph.D., to Scientific Advisory Board
January 6, 2022
Ambagon Therapeutics Launches with $85 Million Series A to Advance Pioneering Molecular Glue Platform and Progress Pipeline
Media Contact
Rhiannon Jeselonis
rhiannon@tenbridgecommunications.com
In The News
Michael J. Fox Foundation for Parkinson's Research | April 8, 2023
Ambagon and academic collaborators awarded grant from the Michael J Fox Foundation to study 14-3-3:LRRK2 stabilizers as a neuroprotective therapy for Parkinson’s Disease.